Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc stock is traded at $24.86, with a volume of 31,815. It is down -3.29% in the last 24 hours and up +15.77% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.